首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1439112

機器人輔助內視鏡市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按最終用途（醫院、門診設施、其他）、地區和競爭細分

Robot-assisted Endoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By End-use (Hospitals, Outpatient Facilities, Others), By Region, and By Competition

出版日期: 2024年01月07日 | 出版商:

TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2022 年，全球機器人輔助內視鏡市場估值為 11.9 億美元，預計在預測期內將出現令人印象深刻的成長，到 2028 年複合CAGR為7.78%。在商業領域，幾個關鍵要素，包括增強的診斷能力和更快的速度復甦時期，一直推動著市場的持續擴張。這種持續成長可以追溯到機器人和內視鏡領域的重大技術進步，這些進步催生了更先進、更有效率的機器人輔助內視鏡系統。癌症和胃腸道疾病等慢性疾病的發生率不斷增加，反過來又推動了對尖端內視鏡技術，特別是機器人輔助內視鏡的需求不斷成長。

市場概況
預測期	2024-2028
2022 年市場規模	11.9億美元
2028 年市場規模	18.5億美元
2023-2028 年CAGR	7.78%
成長最快的細分市場	門診設施
最大的市場	北美洲

主要市場促進因素

技術進步

Global Robot-assisted Endoscope Market was valued at USD 1.19 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.78% through 2028. In the realm of business, several key elements, including enhanced diagnostic capabilities and faster recovery times, have been driving a continuous expansion in the market. This persistent growth can be traced back to significant technological advancements in both the robotics and endoscopy sectors, which have given rise to more advanced and efficient robot-assisted endoscope systems. The increasing occurrence of chronic diseases such as cancer and gastrointestinal disorders has in turn fueled a growing need for cutting-edge endoscopic technology, especially robot-assisted endoscopes.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 1.19 Billion
Market Size 2028	USD 1.85 Billion
CAGR 2023-2028	7.78%
Fastest Growing Segment	Outpatient Facilities
Largest Market	North America

Key Market Drivers

Technological Advancements

The global healthcare industry is experiencing a transformative wave, driven by technological innovations that are changing the way medical procedures are conducted. One of the remarkable areas where technology is making a profound impact is the field of robot-assisted endoscopy.

Technological advancements have brought forth more sophisticated robotic systems. These systems offer enhanced precision, control, and maneuverability. The precise manipulation of robot-assisted endoscope instruments allows healthcare professionals to perform intricate procedures with unprecedented accuracy. As a result, patients benefit from minimally invasive procedures that reduce the risks associated with conventional open surgeries, leading to quicker recovery times.

Modern robot-assisted endoscope systems are equipped with state-of-the-art imaging and sensor technologies. High-definition cameras and advanced sensors enable real-time, high-resolution visualization of the patient's internal anatomy. This level of detail is invaluable for accurate diagnostics and precise intervention. By harnessing these technologies, healthcare providers can offer a higher standard of care, thereby increasing the demand for robot-assisted endoscopy.

Artificial intelligence (AI) is playing an increasingly vital role in robot-assisted endoscopy. AI-driven algorithms can assist healthcare professionals in the interpretation of complex data and images. These AI systems can provide real-time feedback during procedures, suggesting the optimal course of action, and even identifying abnormalities that might be missed by the human eye. Such automation and decision support not only improve the quality of healthcare but also reduce the workload on medical staff, ultimately contributing to market growth.

Telemedicine is on the rise, and robot-assisted endoscopy is no exception. Technological advancements enable surgeons to perform procedures remotely using robotic systems. This is particularly beneficial in scenarios where a specialist is not physically present, or when time-sensitive interventions are required. As the global healthcare landscape continues to adopt telemedicine, the demand for robot-assisted endoscopy systems with remote surgical capabilities is poised to grow significantly.

Technological progress has made robot-assisted endoscope systems highly customizable and adaptable to the unique needs of different medical procedures. Surgeons can configure these systems to suit the specific requirements of a given operation. This flexibility is a significant selling point for hospitals and healthcare facilities, as it allows them to optimize their resources and better meet the diverse needs of their patients.

Enhanced Diagnostic Capabilities

The global healthcare industry is witnessing a profound transformation, with advanced technologies driving monumental shifts in medical practices and patient care. Among these innovations, the incorporation of enhanced diagnostic capabilities in robot-assisted endoscopy is emerging as a pivotal factor in the growth of this dynamic market.

Enhanced diagnostic capabilities have brought about a seismic shift in the world of robot-assisted endoscopy. The integration of cutting-edge imaging technologies, such as high-definition cameras and advanced sensors, has ushered in an era of unprecedented clarity and precision. These technologies offer healthcare professionals crystal-clear visual information, enabling them to make accurate diagnoses with unparalleled confidence. With enhanced imaging capabilities, robot-assisted endoscope systems provide magnified, high-resolution views of internal anatomical structures. This level of detail allows for early detection of anomalies, identification of subtle tissue changes, and precise targeting of treatment areas. As a result, patients receive more accurate diagnoses and tailored treatments, thereby contributing to the market's growth.

Modern robot-assisted endoscope systems are increasingly equipped with artificial intelligence (AI) algorithms. These AI-driven systems can analyze complex data and images in real time, providing valuable feedback to surgeons during procedures. Such technology can identify abnormalities that may be challenging to discern with the human eye alone. It can also offer recommendations on the best course of action, assisting healthcare professionals in making critical decisions swiftly and accurately. The availability of real-time feedback and decision support reduces the margin of error in diagnoses and procedures. This fosters greater trust in robot-assisted endoscopy among healthcare practitioners and institutions. As a result, there is a surge in demand for these systems, propelling market growth.

Enhanced diagnostic capabilities directly translate to improved patient outcomes. Early detection of diseases, such as cancer or gastrointestinal disorders, significantly increases the chances of successful treatment and recovery. Timely and accurate diagnoses mean that patients can receive targeted interventions, leading to better long-term health prospects. The positive impact on patient outcomes not only benefits individuals but also bolsters the reputation of healthcare facilities and providers. As a result, there is a growing preference for robot-assisted endoscopy in medical practices worldwide, spurring market expansion.

The quest for further enhancements in diagnostic capabilities fuels ongoing research and development in the field of robot-assisted endoscopy. Innovations are continuously sought to push the boundaries of imaging, sensor technologies, and AI applications. This environment of innovation is a driving force behind the market's growth, as healthcare professionals and patients eagerly anticipate the next breakthrough in diagnostic accuracy and precision.

Quicker Recovery Periods

In the realm of modern healthcare, the concept of quicker recovery periods has emerged as a game-changer. The demand for faster recuperation and shorter hospital stays has become a priority for both patients and healthcare professionals. The global robot-assisted endoscope market is experiencing significant growth, partly due to its role in facilitating quicker recovery periods.

The hallmark of robot-assisted endoscopy is its minimally invasive nature. Unlike traditional open surgeries, which require large incisions, robot-assisted endoscopic procedures involve small, precise incisions. These minimally invasive surgeries result in less trauma to the patient's body, reduced pain, and significantly lower risk of complications. Consequently, patients experience quicker recovery periods, often returning to their daily routines sooner than with conventional procedures. The appeal of minimally invasive procedures has led to a surge in demand for robot-assisted endoscope systems. Patients and healthcare professionals alike prefer these techniques because they promote better post-operative experiences, offering a strong impetus for market growth.

Shorter hospital stays are another vital component of quicker recovery periods. Traditional surgeries often require extended hospitalization, which can lead to increased healthcare costs and a higher risk of hospital-acquired infections. Robot-assisted endoscopic procedures, on the other hand, allow patients to spend less time in the hospital. This not only reduces the financial burden on patients but also eases the strain on healthcare institutions. Shorter hospitalization times are an attractive feature for patients and healthcare providers, as they enable resources to be allocated more efficiently. As a result, the global robot-assisted endoscope market continues to expand, driven by the growing preference for procedures that facilitate quicker patient discharges.

Quicker recovery periods foster enhanced postoperative comfort. Patients who undergo robot-assisted endoscopic procedures report experiencing less pain and discomfort compared to their counterparts who undergo traditional open surgeries. Improved comfort is a significant factor in patient satisfaction and contributes to positive feedback and word-of-mouth referrals. The potential for a more comfortable recovery experience is an influential driver for patients considering robot-assisted endoscopy. It not only benefits patients but also encourages healthcare professionals to recommend these procedures, further propelling the growth of the market.

The successful deployment of robot-assisted endoscopy contributes to patient confidence in the healthcare system. When patients experience a quicker and smoother recovery, they are more likely to have trust and faith in the capabilities of medical technology. This renewed trust can lead to greater patient compliance with recommended treatments and follow-up procedures. Quicker recovery periods foster a positive cycle of improved patient confidence, which, in turn, fuels the demand for robot-assisted endoscope systems. This growing preference for efficient and patient-centric care is a significant factor in the market's continuous expansion.

Patient Demand for Minimally Invasive Procedures

In today's healthcare landscape, patient preferences and expectations have evolved significantly. Patients now demand treatments and procedures that offer minimal invasiveness, reduced pain, shorter recovery times, and fewer scars. This shift has played a pivotal role in driving the growth of the global robot-assisted endoscope market.

The demand for minimally invasive procedures is reflective of a broader shift in healthcare preferences. Patients are increasingly informed about their treatment options and often seek interventions that allow for quicker recovery and reduced discomfort. This is especially pertinent in the realm of surgery, where traditional open procedures can entail longer hospital stays and more extended recuperation periods. Robot-assisted endoscopy addresses these concerns by offering a minimally invasive alternative. This shift in patient preferences is a driving force behind the market's remarkable growth, as healthcare providers strive to meet the needs and expectations of their clientele.

Minimally invasive procedures are renowned for their ability to minimize pain and discomfort. Robot-assisted endoscopic surgeries involve smaller incisions and cause less trauma to the patient's body compared to open surgeries. This leads to reduced post-operative pain and discomfort, often allowing patients to discontinue pain medications more rapidly. The prospect of a more comfortable recovery experience is a significant draw for patients considering robot-assisted endoscopy. They appreciate the diminished suffering associated with these procedures and are more likely to opt for them over traditional alternatives. This preference significantly contributes to the market's expansion.

Patients increasingly value quicker recovery periods. Long hospital stays and extended recuperation times can disrupt their lives, leading to lost income and time away from work, family, and daily activities. Minimally invasive procedures, such as those provided by robot-assisted endoscopy, reduce these disruptions. Patients undergoing robot-assisted procedures can often return to their normal routines more rapidly. The reduced recovery times associated with these surgeries are a strong driver of patient demand, further propelling the growth of the robot-assisted endoscope market.

Patients are also concerned about post-operative scarring. Large, visible scars can be a source of distress and self-consciousness for many individuals. Robot-assisted endoscopy's minimally invasive approach results in smaller, less conspicuous scars, which is an appealing feature for those seeking a more aesthetically pleasing outcome. The reduced scarring associated with robot-assisted procedures is a compelling factor that attracts patients to these interventions. This heightened patient interest fosters the market's growth, as healthcare providers prioritize patient satisfaction and aesthetic outcomes.

Patients have increasing confidence in cutting-edge medical technology. The use of robotic systems in healthcare procedures is seen as a symbol of progress and innovation. Patients are more likely to trust healthcare providers who offer state-of-the-art treatments, such as robot-assisted endoscopy, which they perceive as more precise and advanced. The growing demand for minimally invasive procedures using robotic technology underscores the market's growth, as healthcare providers invest in these innovative solutions to meet patient expectations and preferences.

Key Market Challenges

High Initial Costs

One of the primary challenges in the adoption of robot-assisted endoscope systems is the high initial costs associated with purchasing, installing, and maintaining these systems. The capital investment required to acquire robotic equipment and ensure that healthcare facilities have the necessary infrastructure and skilled personnel can be prohibitive for many institutions, particularly in resource-constrained settings.

Limited Access to Training and Expertise

Utilizing robot-assisted endoscope systems effectively requires specialized training and expertise. Healthcare professionals must become proficient in operating and troubleshooting these advanced systems. The shortage of healthcare professionals with the necessary skills and expertise can limit the widespread adoption of robot-assisted endoscopy.

Regulatory and Certification Hurdles

The introduction of new medical technologies often faces regulatory hurdles, and robot-assisted endoscope systems are no exception. Navigating the complex regulatory landscape to obtain necessary approvals and certifications can be a lengthy and costly process. Stringent regulations can slow down the market's growth and innovation.

Key Market Trends

Artificial Intelligence and Machine Learning Integration

The integration of artificial intelligence (AI) and machine learning into robot-assisted endoscope systems is becoming increasingly prevalent. AI algorithms can analyze real-time data, assist in decision-making, and provide valuable insights during surgeries. Machine learning models can optimize procedural workflows and improve the overall performance of these systems. This trend is set to make robot-assisted endoscopy even more accurate, efficient, and data-driven.

Miniaturization and Portability

Advancements in robotics and engineering are making robot-assisted endoscope systems more compact and portable. Smaller, more maneuverable robots can access tighter spaces within the body, expanding the range of procedures that can be performed. This trend is opening up new possibilities for endoscopic interventions and making robot-assisted procedures more versatile and adaptable.

Single-port and Multi-arm Systems

Single-port robot-assisted endoscope systems are emerging as a trend that can reduce the invasiveness of procedures even further. These systems are designed to perform multiple tasks through a single-entry point, minimizing scarring and accelerating recovery times. Moreover, multi-arm robotic systems are enhancing the capabilities of robot-assisted endoscopy by offering greater flexibility and dexterity during procedures.

Segmental Insights

End-use Insights

Based on the category of End-use, the outpatient facilities sector held a dominant position in the market during 2022. This sector comprises day surgery clinics and ambulatory surgery centers (ASCs), which have increasingly incorporated robot-assisted endoscopes into their medical procedures. Outpatient facilities are committed to providing patients with convenient and efficient healthcare. They prioritize minimally invasive procedures whenever feasible in order to align with the overarching objective of achieving less invasive diagnostic and treatment alternatives through the use of robot-assisted endoscopes.

Robot-assisted endoscopes are particularly attractive for outpatient environments because they frequently result in shorter recovery and surgery times. Moreover, this segment is projected to experience the highest CAGR from 2023 to 2030. Robot-assisted endoscopes can help reduce the need for more complex surgical procedures and shorten hospital stays, thereby offering a cost-effective solution for outpatient facilities. Given the increasing prevalence of gastrointestinal disorders and other conditions requiring endoscopic procedures, outpatient facilities are likely to experience growing demand for such treatments. Robotic endoscopes are well-suited to effectively meet this rising demand.

Regional Insights

In 2022, the North American region asserted its dominance in the global market. This was facilitated by several key factors: the well-established healthcare industry, the financial capacity of hospitals to invest in robotic endoscopy equipment, heightened public awareness of robot-assisted medical procedures, and the substantial presence of major market players in the region. Additionally, the market experienced growth due to the increasing number of clinical trials related to robot-assisted endoscopes. For example, in December 2022, the first patient was enrolled in the Extend URO clinical study for the Hugo robotic surgical assistance in the United States, as reported by Medtronic plc, a prominent global healthcare technology company.

Further contributing to market expansion in North America, Dr. Michael R. Abern successfully performed a robotic-assisted prostate procedure at Duke University Hospital in North Carolina. Over the forecasted period, the market is expected to benefit from the accessibility and widespread utilization of advanced robotic endoscopy systems. An illustration of this is the Flex robotic system, a surgical platform featuring a flexible robotic endoscope, as detailed in information released by the City of Hope Cancer Center in May 2022. This innovative technology enables surgeons to access challenging areas of the mouth and throat. Otolaryngologists at the Cancer Treatment Centers of America (CTCA) have received comprehensive training in utilizing the Flex robotic system to treat patients with head and neck cancer. The availability of such cutting-edge robotic endoscopic tools in North America underscores the region's commitment to adopting advanced technologies, which is expected to further accelerate market growth during the projected period.

Looking ahead, the Asia Pacific region is anticipated to register the highest CAGR during the forecast period. This regional demand is expected to be driven by factors such as increased disposable income, rising healthcare expenditures, and the prevalence of chronic illnesses. Furthermore, the growing adoption of robotic systems in healthcare facilities is projected to fuel the demand. Additionally, increased investment in cutting-edge medical technologies and procedures, including robotic-assisted endoscopies, has been spurred by the escalating healthcare spending in countries like China and India.

Key Market Players

Asensus Surgical Inc

Intuitive Surgical Inc

Auris Health Inc

Johnson & Johnson

Brainlab AG

Medtronic PLC

Boston Scientific Corp

Stryker Corp

Report Scope:

In this report, the Global Robot-assisted Endoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Robot-assisted Endoscope Market, By End-use:

Hospitals
Outpatient Facilities
Others

Robot-assisted Endoscope Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
Japan
India
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Robot-assisted Endoscope Market.

Available Customizations:

Global Robot-assisted Endoscope market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Robot-assisted Endoscope Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By End-use (Hospitals, Outpatient Facilities, Others)
- 5.2.2. By Region
- 5.2.3. By Company (2022)
5.3. Product Market Map
- 5.3.1. By End-use
- 5.3.2. By Region

6. North America Robot-assisted Endoscope Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By End-use (Hospitals, Outpatient Facilities, Others)
- 6.2.2. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Robot-assisted Endoscope Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By End-use
- 6.3.2. Canada Robot-assisted Endoscope Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By End-use
- 6.3.3. Mexico Robot-assisted Endoscope Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By End-use

7. Europe Robot-assisted Endoscope Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By End-use (Hospitals, Outpatient Facilities, Others)
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Robot-assisted Endoscope Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By End-use
- 7.3.2. United Kingdom Robot-assisted Endoscope Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By End-use
- 7.3.3. France Robot-assisted Endoscope Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By End-use
- 7.3.4. Italy Robot-assisted Endoscope Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By End-use
- 7.3.5. Spain Robot-assisted Endoscope Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By End-use

8. Asia-Pacific Robot-assisted Endoscope Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By End-use (Hospitals, Outpatient Facilities, Others)
- 8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Robot-assisted Endoscope Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By End-use
- 8.3.2. Japan Robot-assisted Endoscope Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By End-use
- 8.3.3. India Robot-assisted Endoscope Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By End-use
- 8.3.4. Australia Robot-assisted Endoscope Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By End-use
- 8.3.5. South Korea Robot-assisted Endoscope Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By End-use

9. South America Robot-assisted Endoscope Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By End-use (Hospitals, Outpatient Facilities, Others)
- 9.2.2. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Robot-assisted Endoscope Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By End-use
- 9.3.2. Argentina Robot-assisted Endoscope Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By End-use
- 9.3.3. Colombia Robot-assisted Endoscope Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By End-use

10. Middle East and Africa Robot-assisted Endoscope Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By End-use (Hospitals, Outpatient Facilities, Others)
- 10.2.2. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Robot-assisted Endoscope Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By End-use
- 10.3.2. Saudi Arabia Robot-assisted Endoscope Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By End-use
- 10.3.3. UAE Robot-assisted Endoscope Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By End-use
- 10.3.4. Kuwait Robot-assisted Endoscope Market Outlook
  - 10.3.4.1. Market Size & Forecast
    - 10.3.4.1.1. By Value
  - 10.3.4.2. Market Share & Forecast
    - 10.3.4.2.1. By End-use

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Asensus Surgical Inc
- 14.1.1. Business Overview
- 14.1.2. Product Offerings
- 14.1.3. Recent Developments
- 14.1.4. Financials (As Reported)
- 14.1.5. Key Personnel
- 14.1.6. SWOT Analysis
14.2. Intuitive Surgical Inc
14.3. Auris Health Inc
14.4. Johnson & Johnson
14.5. Brainlab AG
14.6. Medtronic PLC
14.7. Boston Scientific Corp
14.8. Stryker Corp